🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open label multicentric randomized phase II trial, using high throughput ge...
Status
Completed
Location
Centre Hospitalier Henri Duffau
Start Date
2014-04-23
Trial ID
NCT02117167
The standard of care for muscle-invasive bladder cancer (MIBC) is radical c...
Status
Completed
Location
ICO Badalona
Start Date
2018-11-16
Trial ID
NCT03534492
Treatments Being Tested
This pilot phase I trial studies whether it is feasible to conduct a detail...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2018-05-03
Trial ID
NCT03544125
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of olaparib wh...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2017-06-29
Trial ID
NCT02953457
Treatments Being Tested
This is a Phase 1 dose-escalation study to evaluate the safety and tolerabi...
Status
Recruiting
Location
National University Hospital
Start Date
2018-12-03
Trial ID
NCT03772561
Treatments Being Tested
First-line gemcitabine plus cisplatin chemotherapy is the standard first-li...
Status
Recruiting
Location
Asan Medical Center
Start Date
2022-04-01
Trial ID
NCT05222971
Treatments Being Tested
This study is a pilot study of biomarker-driven targeted therapy in patient...
Status
Unknown
Location
Seoul National University Hospital
Start Date
2018-11-26
Trial ID
NCT03699449
This phase I trial tests the safety and tolerability of olaparib in combina...
Status
Active Not Recruiting
Location
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Start Date
2023-05-22
Trial ID
NCT05411094
The goal of this phase 2 clinical trial is to learn if the three treatments...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06650709
Treatments Being Tested
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested